hsa05200: Pathways in cancer |
8 |
1.631×10−3
|
CDKN1A, CTBP1, HSP90B1, ERBB2, PML, FGF13, FZD3, ZBTB16 |
hsa04010: MAPK signaling pathway |
7 |
1.906×10−3
|
MAP3K7, RPS6KA5, RPS6KA6, MKNK2, FGF13, RKACB, GADD45A |
hsa00230: Purine metabolism |
5 |
2.757×10−3
|
POLR2J, PNPT1, PDE5A, PDE4D, POLR2D |
hsa04621: NOD-like receptor signaling pathway |
3 |
5.778×10−3
|
MAP3K7, HSP90B1, TNFAIP3 |
hsa04115: p53 signaling pathway |
3 |
6.723×10−3
|
CDKN1A, GADD45A, TP73 |
hsa04120: Ubiquitin mediated proteolysis |
4 |
6.914×10−3
|
PRPF19, UBE2D4, UBE2A, PML |
hsa04310: Wnt signaling pathway |
4 |
8.490×10−3
|
MAP3K7, CTBP1, FZD3, PRKACB |
hsa04540: Gap junction |
3 |
1.024×10−2
|
TUBA8, TUBA4A, PRKACB |
hsa04020: Calcium signaling pathway |
4 |
1.153×10−2
|
ERBB2, PRKACB, MYLK, F2R |
hsa04080: Neuroactive ligand-receptor interaction |
3 |
3.522×10−2
|
LEP, S1PR3, F2R |
hsa04630: Jak-STAT signaling pathway |
2 |
3.876×10-2
|
LEP, IL12B |